# Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)

> **NCT02857400** · NA · COMPLETED · sponsor: **Institut Claudius Regaud** · enrollment: 667 (actual)

## Conditions studied

- METASTATIC CANCER

## Interventions

- **OTHER:** current standard of care
- **OTHER:** CREDO standard of care

## Key facts

- **NCT ID:** NCT02857400
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-21
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 667 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02857400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02857400, "Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02857400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*